Biotech

All Articles

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has actually axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) adva...

Daiichi pays Merck $170M to develop bronchi cancer cells T-cell engager treaty

.Merck &amp Co. has promptly recouped a number of the expenses of its Harp on Therapeutics acquistio...

BioMarin stops preclinical genetics treatment for heart disease

.After BioMarin conducted a spring clean of its own pipe in April, the business has actually chosen ...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks handle

.Large Pharmas remain stuck to the suggestion of molecular adhesive degraders. The latest provider t...

Life science debt agency introduces along with $600M

.A brand-new worldwide life science credit score organization, nicknamed Symbiotic Resources, has ac...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing yet another big bet from the Caforio time, canceling a bargain for Ag...

Nuvation halts wager inhibitor after looking at stage 1 data

.After checking out at stage 1 data, Nuvation Bio has actually chosen to halt service its own one-ti...

' Medical intuitiveness' led FDA consultants to back Zevra's uncommon illness med

.Zevra Therapies' rare ailment medicine seems to be to become on the course to authorization this fa...

Pfizer takes $230M struck after axing neglected DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has gone a $230 tho...

AC Immune finds 'landmark' potential in Alzheimer's drug records

.After more than two decades of work with neurodegenerative diseases, Swiss biotech AC Immune system...